Aditxt, Inc. has announced an amendment to their merger agreement with Evofem Biosciences, which includes a $1.5 million investment and extends the closing date to September 30, 2025, based on events reported from December 11, 2023.
AI Assistant
ADITXT INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.